Levofloxacin

Publication Title: 
The Journal of International Medical Research

The efficacy of tamsulosin in the treatment of chronic non-bacterial prostatitis was evaluated in a randomized clinical observation of 105 male outpatients conducted for 90 days. Patients were randomly divided into five groups (n = 21 per group) according to prostatitis type IIIA or IIIB and therapy regimens (tamsulosin, levofloxacin, or tamsulosin plus levofloxacin combination therapy).

Author(s): 
Ye, Z. Q.
Lan, R. Z.
Yang, W. M.
Yao, L. F.
Yu, X.
Publication Title: 
Andrologia

To investigate the association between eradication of Chlamydia trachomatis (CT) and symptom regression in chronic prostatitis, 55 symptomatic patients were subjected to segmented tests to localise CT in first voided urine (VB1), prostatic secretions (EPS), post-massage voided (VB3) or semen specimens. Patients were divided in three treatment groups: the 'urethral involvement' group ('U': VB1 positive, EPS/VB3/Semen negative) was treated with 500 mg day(-1) azithromycin for 3 days.

Author(s): 
Magri, V.
Marras, E.
Skerk, V.
Markotić, A.
Restelli, A.
Garlaschi, M. C.
Perletti, G.
Publication Title: 
Antimicrobial Agents and Chemotherapy

The effects of single coadministrations of one of three traditional Chinese medicines, Hotyu-ekki-to, Rikkunshi-to, and Juzen-taiho-to, on the pharmacokinetics of levofloxacin (LVFX) were investigated with eight healthy volunteers in an open, random crossover fashion. Subjects each received a single oral dose of LVFX (200 mg) alone and then with a single coadministration of each Chinese medicine. There were no significant differences in any pharmacokinetic parameters of LVFX between the groups.

Author(s): 
Hasegawa, T.
Yamaki, K.
Muraoka, I.
Nadai, M.
Takagi, K.
Nabeshima, T.
Subscribe to RSS - Levofloxacin